StockWatch
·

BERYL DRUGS LTD. Q3 FY26 Results

BERLDRGQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue3.7826.2%28.9%
Total Income3.8525.3%28.7%
Expenditure4.468.9%14.9%
PBT-0.61333.5%477.5%
Net Profit-0.171984.3%422.5%
OPM-7.19%20.77pp0.31pp
NPM-4.36%4.53pp5.32pp
EPS0.331550.0%230.0%
View full financials

Informational and educational content only. Not investment advice.